Cancer Treatment Centers of America announced new partnerships with Allscripts and NantHealth. Together these forces will be able to provide oncologists with the most up-to-date and evidence-based treatments.
The future of treatments for cancer is moving toward a personalized approach. The partnership of these companies proves that patients and oncologists are not only looking for an improved quality of life but also for treatment regimes that are successful and innovative.
The implementation of eviti®, which is a support solution from NantHealth that provides clinical decisions, will be used to provide custom solutions. Ultimately the complexity of cancer care data will be at the fingertips of oncologists providing care. The best treatments available will be quickly accessed and administered to patients.
Cancer Treatment Centers of America currently has five hospitals in the US that serves cancer patients. They are known for their integrative approach to dealing with cancer through radiation, chemotherapy, surgery and dealing with side effects like pain and nausea. Allscripts deals with solutions using technology in operations, financial, and clinical, while NantHealth is able to provide evidence-based treatments that are personalized. They are the data keepers of regimens most effective for types of cancers in certain types of patients.
When it comes to finding the right treatment, oncologists have to consider a variety of topics that include types of treatments, cost, and how effective the treatments are based on the evidence available. Cancer Treatment Centers of America is leading the way by integrating the specialties of Allscripts and NantHealth. This partnership will also help to further our understanding of cancer and through more personal approaches increase the likelihood of patients being able to fight off the disease completely.